Number of Shares
11,985.00
Current Holdings Value*
kr830,710.00
% of Portfolio
1.65%
Total Estimate Gain
kr-798,701.10
% of Total Estimate Gain
-8.36%

Lazard International Equity Select Portfolio's Novo Nordisk AS Holding Summary

As of 2025-03-31, LAZARD FUNDS INC held 11,985.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr830,710.00. This investment constitutes 1.65% of their stock portfolio, and LAZARD FUNDS INC now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2023Q2. And since then Lazard International Equity Select Portfolio has made 3 purchases of OCSE:NOVO B, at an average price of kr593.12, for a total of 16,109.00 shares. In addition, there have been 3 sales at an average price of kr811.59 for 4,124.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, Lazard International Equity Select Portfolio's estimated gain on his OCSE:NOVO B holdings is kr-798,701.10, reflecting a -8.36% gain to date.

Lazard International Equity Select Portfolio OCSE:NOVO B (kr451.30) Holding Chart

Lazard International Equity Select Portfolio OCSE:NOVO B (kr451.30) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1